HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features

Ayele Argaw-Denboba(Max Planck Institute of Immunobiology and Epigenetics), Claudia Matteucci(University of Rome Tor Vergata)
Journal of Experimental & Clinical Cancer Research
January 26, 2017
Cited by 70


Related Papers